Angela Bachi Lab
@bachi_lab
ID: 1215550886325387264
https://www.ifom.eu/en/cancer-research/research-labs/research-lab-bachi.php 10-01-2020 08:28:25
66 Tweet
101 Followers
104 Following
Our brand new instrument Orbitrap #Exploris240 from Thermo Fisher is finally flashing into new exciting metabolomics projects in Angela Bachi Lab at IFOM! šš»ššš»
Happy to share this publication. This was a side project for two very busy fellows, but we were lucky to have a very talented MSc student to help us. I am proud of how it turned out, thanks to MarĆa Jimenez-Sanchez who lead all the publication process. š§µ onlinelibrary.wiley.com/doi/10.1111/jnā¦
Glad to share this collaboration with ā¦ā¦ā¦ā¦Bea Gomezā© and ā¦Angela Bachi Labā©!Great work from Vittoria Matafora, Alena Gorb and Fangjia Yang, and thanks ā¦@wendyjnobleā©. Looking at #astrocyte secretome in response to amyloid betašš» onlinelibrary.wiley.com/doi/full/10.11ā¦
10 amazing opportunities for PhD candidates @ IFOM through SEMM in IFOM labs: explore them all, apply and pls circulate among your contacts! semm.it/education/open⦠Bardelli Lab | Angela Bachi Lab | Pagani Lab | Fabrizio d'Adda di Fagagna |ylli doksani | Polo Lab | Scita_Lab
Elegant work by Kristina Havas IFOM showing how interclonal metabolic cooperation contributes to overcoming growth barriers to metastasis. Glad to have contributed with StephanKamrad Rui MRC Toxicology Unit science.org/doi/10.1126/scā¦
The Mark Foundation team spent a wonderful day of science, art, and espresso at IFOM hosted by Alberto Bardelli - thanks for sharing your research with us! Bardelli Lab Angela Bachi Lab Fabrizio d'Adda di Fagagna Pagani Lab Polo Lab @BeckyABC
šØNew Study Alert!šØ Our latest #TBT study out in Science Translational Medicine š„ Acetyl-CoA carboxylase 1 controls a lipid dropletāperoxisome axis and is a vulnerability of endocrine-resistant ER+ breast cancer | Science Translational Medicine science.org/doi/10.1126/sc⦠a brief š§µ
š Excited to see our work now published EMBO Mol. Medicine Inhibition of Asparagine Synthetase Retards PKD progression. ASNS in PKD drives glutamine utilization. Work started by Christine Podrini, completed by Sara Clerici Thanks to collaborators FrezzaLab Angela Bachi Lab Angelo D'Alessandro